In vivo antiaggregatory action of platelet-activating factor in beagle dogs

Role for prostacyclin

F. Herman, K. Magyar, J. G. Filep

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The effects of platelet-activating factor (PAF) on in vivo platelet aggregation were studied in anaesthetized beagle dogs by using the extracorporeal filter-loop technique. Intraarterial administration of PAF caused an immediate increase in filter pressure, indicating enhanced in vivo platelet aggregation. Intravenous administration of PAF (3-100 ng kg-1) resulted in a transient dose-dependent inhibition of spontaneous platelet aggregation on the filter with concomitant elevation in plasma 6-keto-PGF(1α) levels. These changes were significantly attenuated by pretreatment of the animals either with BN 52021 (4 mg kg-1), a specific PAF receptor antagonist or with acetylsalicylic acid (25 mg kg-1). Intraarterial infusion of exogenous prostacyclin at concentrations similar to those observed following intravenous PAF administration, resulted in a transient inhibition of the spontaneous platelet aggregation. These data provide evidence for prostacyclin release in response to PAF, and suggest that prostacyclin may mediate the in vivo anti-aggregatory action of PAF in anaesthetized dogs.

Original languageEnglish
Pages (from-to)296-299
Number of pages4
JournalThrombosis and Haemostasis
Volume65
Issue number3
Publication statusPublished - 1991

Fingerprint

Platelet Activating Factor
Epoprostenol
Dogs
ginkgolide B
Platelet Aggregation
Platelet Factor 3
Intra Arterial Infusions
Prostaglandins F
Intravenous Administration
Aspirin
Pressure

ASJC Scopus subject areas

  • Hematology

Cite this

In vivo antiaggregatory action of platelet-activating factor in beagle dogs : Role for prostacyclin. / Herman, F.; Magyar, K.; Filep, J. G.

In: Thrombosis and Haemostasis, Vol. 65, No. 3, 1991, p. 296-299.

Research output: Contribution to journalArticle

@article{203a317565ea42f0ad51b0f42bfb1fef,
title = "In vivo antiaggregatory action of platelet-activating factor in beagle dogs: Role for prostacyclin",
abstract = "The effects of platelet-activating factor (PAF) on in vivo platelet aggregation were studied in anaesthetized beagle dogs by using the extracorporeal filter-loop technique. Intraarterial administration of PAF caused an immediate increase in filter pressure, indicating enhanced in vivo platelet aggregation. Intravenous administration of PAF (3-100 ng kg-1) resulted in a transient dose-dependent inhibition of spontaneous platelet aggregation on the filter with concomitant elevation in plasma 6-keto-PGF(1α) levels. These changes were significantly attenuated by pretreatment of the animals either with BN 52021 (4 mg kg-1), a specific PAF receptor antagonist or with acetylsalicylic acid (25 mg kg-1). Intraarterial infusion of exogenous prostacyclin at concentrations similar to those observed following intravenous PAF administration, resulted in a transient inhibition of the spontaneous platelet aggregation. These data provide evidence for prostacyclin release in response to PAF, and suggest that prostacyclin may mediate the in vivo anti-aggregatory action of PAF in anaesthetized dogs.",
author = "F. Herman and K. Magyar and Filep, {J. G.}",
year = "1991",
language = "English",
volume = "65",
pages = "296--299",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "3",

}

TY - JOUR

T1 - In vivo antiaggregatory action of platelet-activating factor in beagle dogs

T2 - Role for prostacyclin

AU - Herman, F.

AU - Magyar, K.

AU - Filep, J. G.

PY - 1991

Y1 - 1991

N2 - The effects of platelet-activating factor (PAF) on in vivo platelet aggregation were studied in anaesthetized beagle dogs by using the extracorporeal filter-loop technique. Intraarterial administration of PAF caused an immediate increase in filter pressure, indicating enhanced in vivo platelet aggregation. Intravenous administration of PAF (3-100 ng kg-1) resulted in a transient dose-dependent inhibition of spontaneous platelet aggregation on the filter with concomitant elevation in plasma 6-keto-PGF(1α) levels. These changes were significantly attenuated by pretreatment of the animals either with BN 52021 (4 mg kg-1), a specific PAF receptor antagonist or with acetylsalicylic acid (25 mg kg-1). Intraarterial infusion of exogenous prostacyclin at concentrations similar to those observed following intravenous PAF administration, resulted in a transient inhibition of the spontaneous platelet aggregation. These data provide evidence for prostacyclin release in response to PAF, and suggest that prostacyclin may mediate the in vivo anti-aggregatory action of PAF in anaesthetized dogs.

AB - The effects of platelet-activating factor (PAF) on in vivo platelet aggregation were studied in anaesthetized beagle dogs by using the extracorporeal filter-loop technique. Intraarterial administration of PAF caused an immediate increase in filter pressure, indicating enhanced in vivo platelet aggregation. Intravenous administration of PAF (3-100 ng kg-1) resulted in a transient dose-dependent inhibition of spontaneous platelet aggregation on the filter with concomitant elevation in plasma 6-keto-PGF(1α) levels. These changes were significantly attenuated by pretreatment of the animals either with BN 52021 (4 mg kg-1), a specific PAF receptor antagonist or with acetylsalicylic acid (25 mg kg-1). Intraarterial infusion of exogenous prostacyclin at concentrations similar to those observed following intravenous PAF administration, resulted in a transient inhibition of the spontaneous platelet aggregation. These data provide evidence for prostacyclin release in response to PAF, and suggest that prostacyclin may mediate the in vivo anti-aggregatory action of PAF in anaesthetized dogs.

UR - http://www.scopus.com/inward/record.url?scp=0025774787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025774787&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 296

EP - 299

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 3

ER -